Clinical Trials Directory

Trials / Completed

CompletedNCT02944981

Gabapentin to Reduce Postoperative Nausea and Vomiting

Gabapentin Premedication to Reduce Postoperative Nausea and Vomiting in Surgical Patient Receiving Spinal Morphine

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Khon Kaen University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The intrathecal administration of morphine is gaining popularity. It is easy to do and can reduce the pain after surgery up to 24 hours. However, it causes postoperative nausea and vomiting more than other methods providing postoperative analgesia. Patients suffering from these side effects have to spend a longer period of time recovering in the hospital with high cost of medical treatment.

Detailed description

Objective: to study the efficacy of oral administrating of gabapentin 600 mg before surgery to reduce the postoperative nausea and vomiting in patients receiving intrathecal morphine. Methods: Eighty patients undergoing orthopedic surgery and receiving intrathecal morphine will be randomized into 2 groups. The first group will receive oral gabapentin 600 mg and the second group will receive a placebo tablet. Both groups will receive a standard prophylactic medication for postoperative nausea and vomiting. The degrees of nausea and vomiting in both groups will be assessed over 24 hours postoperatively.

Conditions

Interventions

TypeNameDescription
DRUGGabapentinSingle oral dose
DRUGPlaceboSingle oral dose

Timeline

Start date
2016-08-01
Primary completion
2017-02-01
Completion
2017-02-01
First posted
2016-10-26
Last updated
2017-05-11

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02944981. Inclusion in this directory is not an endorsement.